- Home
- OFLX vs MBX Comparison
OFLX vs MBX Comparison
Compare OFLX & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- MBX
- Stock Information
- Founded
- OFLX 1975
- MBX 2018
- Country
- OFLX United States
- MBX United States
- Employees
- OFLX N/A
- MBX N/A
- Industry
- OFLX Industrial Specialties
- MBX
- Sector
- OFLX Industrials
- MBX
- Exchange
- OFLX Nasdaq
- MBX NYSE
- Market Cap
- OFLX 344.9M
- MBX 381.4M
- IPO Year
- OFLX 2005
- MBX 2024
- Fundamental
- Price
- OFLX $34.46
- MBX $14.57
- Analyst Decision
- OFLX
- MBX Strong Buy
- Analyst Count
- OFLX 0
- MBX 6
- Target Price
- OFLX N/A
- MBX $37.50
- AVG Volume (30 Days)
- OFLX 67.9K
- MBX 445.5K
- Earning Date
- OFLX 08-04-2025
- MBX 08-16-2025
- Dividend Yield
- OFLX 3.95%
- MBX N/A
- EPS Growth
- OFLX N/A
- MBX N/A
- EPS
- OFLX 1.72
- MBX N/A
- Revenue
- OFLX $99,795,000.00
- MBX N/A
- Revenue This Year
- OFLX N/A
- MBX N/A
- Revenue Next Year
- OFLX N/A
- MBX N/A
- P/E Ratio
- OFLX $20.03
- MBX N/A
- Revenue Growth
- OFLX N/A
- MBX N/A
- 52 Week Low
- OFLX $28.12
- MBX $4.81
- 52 Week High
- OFLX $57.81
- MBX $27.50
- Technical
- Relative Strength Index (RSI)
- OFLX 52.08
- MBX N/A
- Support Level
- OFLX $33.10
- MBX N/A
- Resistance Level
- OFLX $35.43
- MBX N/A
- Average True Range (ATR)
- OFLX 1.65
- MBX 0.00
- MACD
- OFLX -0.07
- MBX 0.00
- Stochastic Oscillator
- OFLX 39.47
- MBX 0.00
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.